NFL: Reports: WFT trainer Ryan Vermillion subject of prescription drug probe

Date:

Share post:


Washington Football Team head trainer Ryan Vermillion is being investigated for illegally distributing prescription drugs, the Washington Post and ESPN reported Thursday.

Federal law enforcement conducted a raid at the team’s practice facility and Vermillion’s home last week. On Monday, Washington placed him on administrative leave, saying in a statement it was “due to an ongoing criminal investigation that is unrelated to the team.”

Vermillion is not a physician, so by law he would not be allowed to disburse prescription drugs.

Earlier Thursday, the NFLPA informed agents that it has begun its own investigation into the matter.

“The work office and home of Ryan Vermillion were raided by the Drug Enforcement Agency, and one of our players has been contacted by federal investigators,” the memo revealed.

According to the initial report from NBC Sports Washington, the investigation into Vermillion has been ongoing for months.

Vermillion is in his second season with Washington after 18 seasons with the Carolina Panthers. He spent nine seasons with Washington coach Ron Rivera in Carolina when Rivera was coach of the Panthers from 2011-19.

–Field Level Media

spot_img

Related articles

NCAAF: LSU lands 5-star WR Derek Meadows

Derek Meadows, a five-star wide receiver from the Class of 2025, committed to LSU on Saturday. Meadows marks the...

NFL: Saints, WR Shahid Rasheed agree to 1-year extension

New Orleans Saints wide receiver and All-Pro returner Rashid Shaheed has agreed to a one-year, $5.2 million contract...

NFL: Jaguars place DL Arik Armstead on PUP list

The Jacksonville Jaguars placed defensive lineman Arik Armstead on the active/physically unable to perform list Saturday. Armstead, 30,...

CFL: Vernon Adams Jr., BC Lions aim to topple Stampeders

Vernon Adams Jr. is coming off a monster game and now faces a team that struggles to pressure...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.